- Anatomy of The Spine
- Back Pain in Children
- Caring for your Spine
- Emerging Spinecare Trends
- Evaluation of Spinal Disorders
- Exercise and The Spine
- Intervention - Spinal Disorders
- Intervertebral Disc
- Non Surgical Options
- Nutrition and Spinecare
- Options for Spine Treatments
- Pregnancy and Back Pain
- Prevalence of Spine Disorders
- Sleep and the Spine
- Spinecare Introduction
- Spinehealth and Disease
- Surgical Interventions
- Treatment with Medications
- Understanding Back Pain
YOU are here : Home > Spinecare Topics > Options for Spine Treatments > Advancements in Spine Care and Spine Surgery
Spinecare Topics
Options for Spine Treatments
Advancements in Spine Care and Spine Surgery
1 2 3 4 5 6 7 8 9
Advancements in Spine Care and Spine Surgery
The future of spine navigation technology is very exciting. Advanced imaging of the spine during surgery will be used more often to create three-dimensional models that the surgeon can use to guide their surgical intervention. Intra-operative CT, MRI and fluoroscopy-based CT imaging offers the greatest potential. The surgeon can magnify the view of his surgical path as well as view in detailed areas that could not be seen during the surgical procedure. Advances in the field of spine navigation will facilitate minimally invasive surgical techniques. Pre-operative CT and MRI scans can be used to render three-dimensional models of the patient’s spine.
Use of Bioresorbable Tissue Implants:
Currently spine surgeons use rigid non-resorbable materials to stabilize or fuse one or more spinal segments. There is growing interest in the use of resorbable materials as a temporary conduit for promoting amore natural fusion process.
Bioresorbable tissue implants can be used to help maintain graft position during bone healing. It will also lead to a reduction of residual hardware, thus minimizing the potential for long-term device related complications. Choosing the right material ideally results in implant resorption through natural elimination of the biochemical byproducts. The more compatible the implant is with adjacent tissues both chemically and structurally the less likely there is to be adverse biomechanical side effects. A radiolucent and bioresorbable spinal implant will not disrupt the quality of post-operative diagnostic imaging of the region rendering the follow up process more efficient. The future use of bioresorbable material will reduce the need for re-operation for device removal and replacement.
Bone Growth Enhancement
For many years, scientists have been looking for ways to stimulate the human body to generate and repair bone more efficiently and rapidly. Spine physicians and spine surgeons have a particular interest in this advancing technology. Thousands of operations of the spine are performed each year that involve surgically directed bony fusion of the spinal column. The current conventional surgical procedures require harvesting of bone chips from the patient’s pelvis and transplantation to the vertebra to help fuse the adjacent vertebra together provide spinal stability. This surgical approach can be effective for certain spinal disorders, although the transplantation process prolongs the time spent in surgery, increases the risk for blood loss, increases the hospital stay, increases recovery time and may be associated with increased post-operative pain. This technique does not always lead to a successful bone graft, adequate bone growth or bridging between the adjacent vertebra.
Scientists and spinal surgeons have revealed that a genetically-produced protein, referred to as recombinant human bone morphogenetic protein-two or rhBMP-2 has the capacity to stimulate an individual’s own bone cells to rapidly make more bone. This approach may eliminate the need for bone transplantation from the pelvis and lead to a more successful surgical outcome. In some cases, the use of bone growth enhancement technology will reduce the need for the use of spinal instrumentation, such as rods and screws. The process of stimulating bone growth is referred to as osteoinduction. The rhBMP-2 was first utilized in 1997 in individuals requiring spinal fusion. Therapeutic trials revealed encouraging results. The surgical application of osteoinductive factors will enable spinal surgeons to improve the efficiency of the surgical approach and improve post-surgical outcome.
Use of Bioresorbable Tissue Implants:
Currently spine surgeons use rigid non-resorbable materials to stabilize or fuse one or more spinal segments. There is growing interest in the use of resorbable materials as a temporary conduit for promoting amore natural fusion process.
Bioresorbable tissue implants can be used to help maintain graft position during bone healing. It will also lead to a reduction of residual hardware, thus minimizing the potential for long-term device related complications. Choosing the right material ideally results in implant resorption through natural elimination of the biochemical byproducts. The more compatible the implant is with adjacent tissues both chemically and structurally the less likely there is to be adverse biomechanical side effects. A radiolucent and bioresorbable spinal implant will not disrupt the quality of post-operative diagnostic imaging of the region rendering the follow up process more efficient. The future use of bioresorbable material will reduce the need for re-operation for device removal and replacement.
Bone Growth Enhancement
For many years, scientists have been looking for ways to stimulate the human body to generate and repair bone more efficiently and rapidly. Spine physicians and spine surgeons have a particular interest in this advancing technology. Thousands of operations of the spine are performed each year that involve surgically directed bony fusion of the spinal column. The current conventional surgical procedures require harvesting of bone chips from the patient’s pelvis and transplantation to the vertebra to help fuse the adjacent vertebra together provide spinal stability. This surgical approach can be effective for certain spinal disorders, although the transplantation process prolongs the time spent in surgery, increases the risk for blood loss, increases the hospital stay, increases recovery time and may be associated with increased post-operative pain. This technique does not always lead to a successful bone graft, adequate bone growth or bridging between the adjacent vertebra.
Scientists and spinal surgeons have revealed that a genetically-produced protein, referred to as recombinant human bone morphogenetic protein-two or rhBMP-2 has the capacity to stimulate an individual’s own bone cells to rapidly make more bone. This approach may eliminate the need for bone transplantation from the pelvis and lead to a more successful surgical outcome. In some cases, the use of bone growth enhancement technology will reduce the need for the use of spinal instrumentation, such as rods and screws. The process of stimulating bone growth is referred to as osteoinduction. The rhBMP-2 was first utilized in 1997 in individuals requiring spinal fusion. Therapeutic trials revealed encouraging results. The surgical application of osteoinductive factors will enable spinal surgeons to improve the efficiency of the surgical approach and improve post-surgical outcome.
1 2 3 4 5 6 7 8 9
